JDD July Issue Highlights | Skin of Color Issue
The July issue of the Journal of Drugs in Dermatology (JDD) focuses on skin of color topics with the perfect mix of original articles, case reports, brief communications, and letters to the editor. Among many of the topics explored in this issue are skin of color dermatology on TikTok, disparities in melanoma recognition in skin of color, diversity in acne clinical trials, dermatologists at skin o …
The July issue of the Journal of Drugs in Dermatology (JDD) focuses on skin of color topics with the perfect mix of original articles, case reports, brief communications, and letters to the editor. Among many of the topics explored in this issue are skin of color dermatology on TikTok, disparities in melanoma recognition in skin of color, diversity in acne clinical trials, dermatologists at skin o … Continue reading "JDD July Issue Highlights | Skin of Color Issue"
“Jello Skin” is a term that dermatology patients – especially TikTok-using patients – may use in their next office visit. A facialist coined the term when describing glowing, bouncy skin with a lot of collagen similar to Jell-O gelatin.
Are you up-to-date on the latest developments and trends in dermatology? Peruse this list of articles in the consumer press and learn about everything fro … 
JDD authors Hannah Polster MD, Karen Kagha MD, and Janiene Luke MD report a case of platelet rich plasma for the treatment of scarring alopecia due to discoid lupus erythematosus.
Platelet-rich plasma (PRP) is an autologous concentration of plasma from a patient's blood containing platelets up to 7 times higher than normal plasma.1 Originally indicated to improve connective tissue regeneratio … 
Our new series, “The Many Faces of”, showcases side-by-side images of some of the most commonly seen dermatology conditions in an array of skin tones and briefly highlight nuances in clinical presentation. All images featured in the series are part of The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas, a resource developed by co-editors Misty Eleryan, MD, MS, and Adam Friedman, … 
Dermatologists are prescribing oral glucocorticoids for psoriasis despite awareness of risks of life-threatening generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP). A recent survey of dermatologists published in the Journal of Drugs in Dermatology found 18% of respondents occasionally prescribe oral glucocorticoids to patients with psoriasis, typically 1-5% of the time. Those wh … 